» Authors » Andrew Retter

Andrew Retter

Explore the profile of Andrew Retter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 385
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Retter A, Singer M, Annane D
Crit Care . 2025 Feb; 29(1):59. PMID: 39905519
Neutrophils release neutrophil extracellular traps (NETs) as part of a healthy host immune response. NETs physically trap and kill pathogens as well as activating and facilitating crosstalk between immune cells...
2.
Camarda V, Sanderson B, Barrett N, Collins P, Garfield B, Gattinoni L, et al.
Crit Care . 2024 Dec; 28(1):403. PMID: 39639320
Background: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a supportive therapy for acute respiratory failure with increased risk of packed red blood cells (PRBC) transfusion. Blood cell salvage (BCS) aims to...
3.
Doyle A, Retter A, Parmar K, Mayger K, Barrett N, Camporota L, et al.
Perfusion . 2024 Jul; :2676591241267218. PMID: 39051475
Introduction: Bleeding and thrombotic events (BTE) are frequent during extracorporeal membrane oxygenation (ECMO). They occur at varying timepoints and may be affected by temporal changes in coagulation and fibrinolysis. We...
4.
Zukas K, Cayford J, Serneo F, Atteberry B, Retter A, Eccleston M, et al.
J Thromb Haemost . 2024 Jun; 22(9):2543-2554. PMID: 38866247
Background: Neutrophils, the most abundant white blood cells in humans, play pivotal roles in innate immunity, rapidly migrating to sites of infection and inflammation to phagocytose, neutralize, and eliminate invading...
5.
Retter A, Hunt B
Hematology Am Soc Hematol Educ Program . 2023 Dec; 2023(1):754-760. PMID: 38066939
A consumptive coagulopathy describes a situation where there is a loss of hemostatic factors, which leads to an increased risk of bleeding. Some recent studies have used the term interchangeably...
6.
Hla T, Christou S, Sanderson B, Hanks F, Cameron L, Camporota L, et al.
ASAIO J . 2023 Dec; 70(4):313-320. PMID: 38039550
Unfractionated heparin (UFH) is the most used anticoagulant in patients receiving veno-venous extracorporeal membrane oxygenation (VV-ECMO). Its therapeutic levels are monitored using activated partial thromboplastin time ratio (aPTTr) or antifactor...
7.
Collins P, Giosa L, Kathar S, Camarda V, Palmesino F, Eshwar D, et al.
Ann Intensive Care . 2023 Sep; 13(1):90. PMID: 37750928
Background: Data on the prevalence and clinical impact of extrapulmonary findings at screening computed tomography (CT) on initiation of veno-venous extracorporeal membrane oxygenation (V-V ECMO) are limited. We aimed to...
8.
Vasques F, Sanderson B, Correa G, Collins P, Camarda V, Giosa L, et al.
ASAIO J . 2023 May; 69(9):849-855. PMID: 37159512
In this retrospective observational cohort study, we aimed to describe the rate of extracorporeal membrane oxygenation (ECMO) circuit change, the associated risk factors and its relationship with patient characteristics and...
9.
Camporota L, Sanderson B, Worrall S, Ostermann M, Barrett N, Retter A, et al.
J Crit Care . 2023 Apr; 77:154313. PMID: 37116437
Background: Despite its diagnostic and prognostic importance, physiologic dead space fraction is not included in the current ARDS definition or severity classification. ARDS caused by COVID-19 (C-ARDS) is characterized by...
10.
Bartlett R, Arachichilage D, Chitlur M, Hui S, Neunert C, Doyle A, et al.
Semin Thromb Hemost . 2023 Feb; 50(1):81-90. PMID: 36750217
Extracorporeal membrane oxygenation (ECMO) was first started for humans in early 1970s by Robert Bartlett. Since its inception, there have been numerous challenges with extracorporeal circulation, such as coagulation and...